Dr. Reddy's Laboratories ... (RDY)
NYSE: RDY
· Real-Time Price · USD
14.22
0.11 (0.78%)
At close: Aug 15, 2025, 3:59 PM
14.22
-0.04%
After-hours: Aug 15, 2025, 05:16 PM EDT
Dr. Reddy's Laboratories Cash Flow Statement
Financials in INR. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 57.42B | 57.24B | 54.44B | 54.19B | 55.58B | 55.68B | 67.62B | 66.31B | 62.63B | 60.48B | 36.35B | 30.94B | 29.74B | 23.57B | 28.23B | 21.36B | 19.06B | 19.15B | 21.26B | 15.36B | 18.66B |
Depreciation & Amortization | 18.01B | 17.06B | 16.22B | 15.27B | 15.08B | 14.84B | 14.18B | 13.68B | 13.02B | 12.5B | 12.4B | 12.11B | 11.97B | 11.82B | 12.04B | 12.28B | 12.56B | 12.8B | 12.59B | 12.46B | 12.53B |
Stock-Based Compensation | 435M | 424M | 408M | 404M | 400M | 407M | 331M | 345M | 359M | 397M | 517M | 565M | 591M | 592M | 580M | 570M | 588M | 584M | 577M | 553M | 528M |
Other Working Capital | 1.84B | -6.95B | -1.59B | -7.51B | -818M | 1.68B | 3.81B | 16.77B | -3.09B | -5.2B | -12.38B | -12.05B | -7.52B | -8.59B | -5.13B | -15.54B | -8.2B | 1.59B | -7.46B | -2.92B | -4.42B |
Other Non-Cash Items | -17.86B | -17.85B | -14.59B | -12.83B | -14.39B | -16.01B | -30.51B | -27.47B | -20.05B | -21.96B | -2.32B | -2B | -5.46B | -2.69B | -9.74B | -2.56B | 1.03B | 2.29B | -26M | 6.33B | 7.55B |
Deferred Income Tax | 19.59B | 19.54B | 18.3B | 18.07B | 16.65B | 16.19B | 16.9B | 16.31B | 16.96B | 15.3B | 13.24B | 12.01B | 9.79B | 8.73B | 9.66B | 9.66B | 7.9B | 9.18B | 6.14B | 3.92B | -342M |
Change in Working Capital | -25.04B | -29.99B | -33.34B | -35.54B | -25.15B | -20.18B | -14.94B | 2.94B | -9.46B | -7.86B | -11.88B | -11.25B | -8.41B | -13.91B | -10.5B | -24.11B | -19.79B | -8.29B | -13.55B | -8.55B | -8.01B |
Operating Cash Flow | 52.56B | 46.43B | 35.95B | 34.07B | 42.68B | 45.43B | 53.59B | 72.11B | 63.47B | 58.87B | 48.31B | 42.39B | 38.21B | 28.11B | 30.25B | 17.19B | 21.34B | 35.7B | 26.98B | 30.07B | 30.92B |
Capital Expenditures | -38.12B | -34.4B | -29.43B | -25.66B | -21.69B | -27.43B | -24.9B | -22.95B | -22.34B | -18.86B | -19.14B | -20.52B | -24.4B | -19.05B | -18.23B | -18.54B | -14.01B | -12.56B | -11.46B | -8.04B | -6.57B |
Cash Acquisitions | -53.15B | -53.1B | -51.44B | -46.4B | 8.98B | 21.15B | 21.15B | 16.11B | 12.17B | n/a | -326M | -326M | 3.3B | 3.44B | 19.07B | 20.99B | 16.84B | 1.71B | -12.99B | -14.75B | -14.1B |
Purchase of Investments | -244.32B | -254.46B | -232.72B | -213.81B | -177.62B | -145.49B | -153.64B | -159.17B | -138.64B | -136.17B | -135.91B | -105.89B | -97.58B | -88.97B | -57.31B | -54.58B | -59.92B | -75.42B | -77.99B | -93.55B | -96.56B |
Sales Maturities Of Investments | 274.05B | 279.58B | 254.06B | 220.96B | 143.89B | 129.78B | 131.21B | 125.22B | 115.33B | 112.81B | 106.8B | 101.67B | 92.46B | 77.77B | 57.7B | 61.73B | 60.81B | 79.53B | 82.49B | 99.11B | 99.77B |
Other Investing Acitivies | -4.03B | -2.28B | -6.17B | -9.9B | -13.76B | -24.88B | -18.53B | -14.14B | -11.19B | 859M | 991M | 1.12B | 524M | 422M | -15.08B | -16.93B | -16.27B | -15.92B | -1.44B | 220M | 503M |
Investing Cash Flow | -57.02B | -58.08B | -56.13B | -66.85B | -52.3B | -40.28B | -44.7B | -54.93B | -44.68B | -41.37B | -47.59B | -23.94B | -25.7B | -26.39B | -13.85B | -7.33B | -12.54B | -22.66B | -21.38B | -17B | -16.96B |
Debt Repayment | 12.67B | 23.2B | 28.34B | 26.82B | 10.27B | -991M | -5.12B | -5.32B | -12.39B | -21.69B | -12.16B | -12.13B | -5.27B | 7.48B | 1.89B | -5.13B | -6.99B | -7.69B | -1.73B | -9B | -7.07B |
Common Stock Repurchased | -1.39B | -1.39B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1B | -1B | -1.19B | -1.19B | -190M | -190M | n/a |
Dividend Paid | -6.66B | -6.66B | -6.66B | -6.66B | -6.65B | -6.65B | -6.65B | -6.65B | -4.98B | -4.98B | -4.98B | -4.98B | -4.15B | -4.15B | -8.28B | -8.28B | -8.28B | -8.28B | -4.75B | -4.75B | -4.52B |
Other Financial Acitivies | 3.17B | 3.57B | -3.2B | 3.03B | 2.89B | 3.07B | 3.25B | -1.33B | -583M | -560M | -484M | -3.62B | -6.29B | -6.09B | 8.16B | 10.17B | 10.91B | 16.59B | 2.32B | 903M | -773M |
Financial Cash Flow | 8.17B | 18.91B | 25.75B | 30.44B | 7.25B | -3.76B | -7.53B | -12.23B | -17.54B | -26.86B | -17.47B | -20.62B | -15.48B | -2.42B | 1.12B | -3.87B | -5.22B | -298M | -3.5B | -12.25B | -11.66B |
Net Cash Flow | 4.09B | 7.49B | 5.5B | -2.25B | -2.31B | 1.33B | 1.28B | 4.44B | 931M | -9.07B | -15.72B | -887M | -1.87B | 32M | 17.66B | 6.19B | 3.77B | 12.86B | 2.08B | 780M | 2.33B |
Free Cash Flow | 14.44B | 12.03B | 6.52B | 8.41B | 20.99B | 18B | 28.69B | 49.16B | 41.12B | 40.01B | 29.17B | 21.87B | 13.81B | 9.06B | 12.03B | -1.35B | 7.33B | 23.14B | 15.53B | 22.03B | 24.35B |